Mackenzie Financial’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.9M Sell
111,039
-13,554
-11% -$3.38M 0.03% 370
2025
Q4
$30.2M Sell
124,593
-35,303
-22% -$9.03M 0.04% 327
2025
Q3
$43.8M Sell
159,896
-90,810
-36% -$24.8M 0.05% 268
2025
Q2
$64.7M Sell
250,706
-7,569
-3% -$1.81M 0.08% 200
2025
Q1
$57.8M Buy
258,275
+93,794
+57% +$21.9M 0.08% 198
2024
Q4
$37.6M Sell
164,481
-47,952
-23% -$11.5M 0.05% 250
2024
Q3
$51.9M Buy
212,433
+45,278
+27% +$10.1M 0.07% 219
2024
Q2
$32M Buy
167,155
+19,995
+14% +$4.06M 0.05% 271
2024
Q1
$29.1M Sell
147,160
-20,605
-12% -$3.78M 0.04% 283
2023
Q4
$28.9M Buy
167,765
+16,260
+11% +$2.5M 0.04% 279
2023
Q3
$21.9M Buy
151,505
+16,966
+13% +$3.07M 0.04% 300
2023
Q2
$28.9M Sell
134,539
-602
-0.4% -$134K 0.04% 274
2023
Q1
$29.6M Buy
135,141
+115,773
+598% +$25.1M 0.05% 283
2022
Q4
$4.03M Buy
19,368
+1,618
+9% +$355K 0.01% 552
2022
Q3
$3.88M Sell
17,750
-1,283
-7% -$292K 0.01% 567
2022
Q2
$3.99M Sell
19,033
-478
-2% -$102K 0.01% 576
2022
Q1
$4.73M Buy
19,511
+2,445
+14% +$591K 0.01% 588
2021
Q4
$4.45M Sell
17,066
-398
-2% -$103K 0.01% 602
2021
Q3
$4.6M Sell
17,464
-3,591
-17% -$982K 0.01% 582
2021
Q2
$5.19M Sell
21,055
-1,375
-6% -$289K 0.01% 555
2021
Q1
$4.35M Buy
22,430
+4,307
+24% +$864K 0.01% 563
2020
Q4
$3.85M Buy
18,123
+1,935
+12% +$386K 0.01% 488
2020
Q3
$2.77M Buy
16,188
+5,991
+59% +$1.11M 0.01% 495
2020
Q2
$1.96M Buy
10,197
+4,852
+91% +$794K 0.01% 563
2020
Q1
$787K Sell
5,345
-55
-1% -$8.76K ﹤0.01% 700
2019
Q4
$837K Buy
5,400
+3,306
+158% +$476K ﹤0.01% 764
2019
Q3
$283K Sell
2,094
-10
-0.5% -$1.31K ﹤0.01% 900
2019
Q2
$257K Sell
2,104
-50
-2% -$5.54K ﹤0.01% 989
2019
Q1
$224K Buy
+2,154
New +$222K ﹤0.01% 1148

Other funds holding RMD